853O OMITting frontline chemotherapy in head and neck cancer (HNSCC) patients with 1-3 oligometastases using stereotactic ablative radiotherapy (SABR), the GORTEC 2014-04 “OMET” randomized phase II trial

J. Thariat, M. Bosset, A. Falcoz, D. Vernerey, Y. Pointreau, S. Racadot, J.C. Faivre, J. Castelli, S. Guihard, F. Huguet, S. Chapet, Y. Tao, J. Bourhis, X.S. Sun,

Annals of Oncology oct 2023, Abstract 8530,Volume 34 suppl 2, S554

Double-blind Randomized Phase 2 Results Comparing Concurrent High-dose Cisplatin Chemorradiation (CRT) plus Debio 1143 or Placebo In High-risk Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): A GORTEC Study

J. Bourhis, X. Sun, Y. Pointreau, C. Sire, C. Le Tourneau, A. Coutte, M. Kaminsky-Forrett, M. Alfonsi, P. Boisselier, L. Martin, J. Delord, F. Clatot, J. Miroir, F. Rolland, P. Crompton, S. Brienza, S.A. Szyldergemajn, C. Even, Y. Tao

Annals of Oncology (2019) 30 (suppl_5): v851-v934. 10.1093/annonc/mdz394

Double-blind Randomized Phase 2 Results Comparing Concurrent High-dose Cisplatin Chemorradiation (CRT) plus Debio 1143 or Placebo In High-risk Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck (SCCHN): A GORTEC Study by Jean Bourhis

ELAN FIT ELAN UNFIT

Barcelona 2019 ESMO Congress - Oral Presentation

Personalized treatment according to geriatric assessment in 1st line recurrent and/or metastatic (r/m) Head and Neck Squamous Cell Cancer (HNSCC) patients aged 70 or over.
Publication PDF

J. Guigay, A. Auperin, C. Mertens, C. Even, L. Geoffrois, D. Cupissol, F. Rolland, C. Sire, J. Fayette, F. Peyrade, E. Blot, P. Debourdeau, L. Bozec Le Moal, O. Capitain, Y. Pointreau, C. Brard, C. Michel, D. Schwob, C. Ortholan, H. Le Caer

Concurrent cisplatin and Dose escalation with Intensity-modulated radiotherapy (IMRT) versus conventional chemo-radiotherapy for locally advanced (LA) head and neck squamous cell carcinomas (HNSCC): GORTEC 2004-01 randomized phase III trial

Y. Tao, A. Auperin, P. Blanchard, M. Alfonsi, X. Sun, M. Rives, Y. Pointreau, J. Castelli, P. Graff, S. Wong Hee Kam, J. Thariat, O. Veresezan, A. Cornely, O. Casiraghi, M. Lapeyre, J. Bourhis

Annals of Oncology (2018) 29 (suppl_8): viii372-viii399. 10.1093/annonc/mdy287

TOPNIVO - A safety study of Nivolumab in Patients with Recurrent and/or Metastatic Platinum-refractory Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN): first results on behalf of the Unicancer Head&Neck Group and the GORTEC.

C. Even, A. Daste, E. Saada-Bouzid, J. Fayette, M. Kaminsky-Forrett, S. Zanetta, A. Prevost, G. Lefebvre, C. Borel, D. Cupissol, F. Huguet, J. Delord, N. Baste Rotllan, J. Delaye, I. Jallut, N. Vintonenko, J. Bourhis, J. Guigay, M. Texier, A. Auperin

Annals of Oncology (2018) 29 (suppl_8): viii372-viii399. 10.1093/annonc/mdy287

1108TiP - Chemoradiotherapy versus radiotherapy in the treatment of salivary glands and nasal tumors: the GORTEC 2016-02 study

F.R. Ferrand, J. Thariat, N. Vulquin, V. Calugaru, O. Malard, C. Murariu, F. Janot, F. Louat, C. Michel, J. Bourhis

Annals of Oncology (2017) 28 (suppl_5): v372-v394. 10.1093/annonc/mdx374

Hope for salivary gland cancer (SGC): EORTC HNCG/UKCRN 1206 randomized phase II study to evaluate the efficacy and safety of Chemotherapy (CT) vs androgen deprivation therapy (ADT) in patients with recurrent and/or metastatic androgen receptor (AR) expressing SGC

L.D. Locati, C. Caballero, C. Fortpied, F. Perrone, S. Pilotti, K.J. Harrington, V. Grégoire, L. Licitra

Annals of Oncology (2017) 28 (suppl_5): v372-v394. 10.1093/annonc/mdx374

Dose escalation of radiotherapy (RT) for locally advanced head and neck carcinomas treated with concomitant chemotherapy (CT) and RT: Results of the GORTEC 2004-01 randomized trial.

Jean Bourhis, Anne Auperin, Marc Alfonsi, xu Shan Sun, Michel Rives, Yoann Pointreau, Cedrik Lafond, Pierre Boisselier, Pierre Graff, Juliette Thariat, Yungan Tao

J Clin Oncol 35, 2017 (suppl; abstr 6015)

Impact of p16 expression on induction taxotere-cisplatin-5 FU (TPF) followed by cetuximab-radiotherapy in N2b-N3 head and neck squamous cell carcinoma (HNSCC): Results of GORTEC 2007-02 phase III randomized trial.

Yungan Tao, Lionnel Geoffrois, Laurent Martin, Dominique De Raucourt, Joelle Miny, Philippe Maingon, Cedrik Lafond, Claude Tuchais, Christian Sire, Emmanuel Babin, Alexandre Coutte, Frederic Rolland, Marie-Helene Girard-Calais, Odile Casiraghi, Pascal Garaud, Jean Bourhis

J Clin Oncol 35, 2017 (suppl; abstr 6070)